Competitive Analysis

Find the signal in the noise. An avalanche of data, including from your competitors, is generated every day. Identifying the key information isn’t enough – you need to understand what it means for you and the market. We have the tools, but more importantly, the insight, to help.

Our Experts

Katie Maloney

Pranay Madan

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Cell and Gene Therapy Services Landscape Assessment

A top-10 scientific service provider wanted to quantify the size of the CGT services market and understand trends within

No items found.

Clinical Diagnostics

NIPT Market Landscape and Strategy

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Go-to-Market Strategy

Clinical Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Clinical Diagnostics

Longitudinal Monitoring of Cancer Early Detection Market

A top-10 diagnostics player wanted to monitor market development activities and competitive intelligence in the early cancer detection space

Competitive Analysis

Pharma & Biotech

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Pharma & Biotech

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

Competitive Analysis

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help